Related Experiment Video
Updated: May 10, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Engineered bacteria detect tumor DNA
Robert M Cooper1, Josephine A Wright2, Jia Q Ng3
1Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA.
Abstract:
Synthetic biology has developed sophisticated cellular biosensors to detect and respond to human disease. However, biosensors have not yet been engineered to detect specific extracellular DNA sequences and mutations. Here, we engineered naturally competent Acinetobacter baylyi to detect donor DNA from the genomes of colorectal cancer (CRC) cells, organoids, and tumors. We characterized the functionality of the biosensors in vitro with coculture assays and then validated them in vivo with sensor bacteria delivered to mice harboring colorectal tumors. We observed horizontal gene transfer from the tumor to the sensor bacteria in our mouse model of CRC. This cellular assay for targeted, CRISPR-discriminated horizontal gene transfer (CATCH) enables the biodetection of specific cell-free DNA.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

